Clinical Trial Update: Ramosetron OD Tablet and Postdischarge Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial update for Ramosetron OD Tablet investigating postdischarge nausea and vomiting in day surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Day Surgery

Drugs mentioned

• Ramosetron OD Tablet (ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Day Surgery | Phase 4 | Status: UNKNOWN